A Phase 2 study of intra-articular injection of DE-098 in patients with rheumatoid arthritis

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221430

Enrollment

Registered

2011-04-14

Start date

2011-04-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

investigational material(s) Generic name etc : Intra-articular injection of DE-098 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with rheumatoid arthritis

Exclusion criteria

Exclusion criteria: Participating in other clinical trials In pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
Efficacy and safety assessment Assessment of the target joint, adverse events (AE) and adverse drug reactions (ADR)	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026